Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

Authors: Raal F.J.¹; Pilcher G.J.; Illingworth D.R.; Pappu A.S.; Stein E.A.; Laskarzewski P.; Mitchel Y.B.; Melino M.R.

Source: Atherosclerosis, Volume 135, Number 2, December 1997 , pp. 249-256(8)

Publisher: Elsevier

Keywords: HMG CoA reductase inhibitors; Simvastatin; Low density lipoprotein-cholesterol; Homozygous familial hypercholesterolaemia

Language: English

Document Type: Research article

DOI: 10.1016/S0021-9150(97)00168-8

Affiliations: 1: Carbohydrate and Lipid Metabolism Research Group, Department of Medicine, University of the Witwatersrand, 7 York Road, Parktown, 2193 Johannesburg, South Africa

Links for this article

http://www.ingentaconnect.com/els/00219150/1997/00000135/00000002/art00168
http://openurl.ingenta.com/content?genre=article&issn=0021-9150&volume=135&issue=2&spage=249&epage=256
http://dx.doi.org/10.1016/S0021-9150(97)00168-8